Publications
1. AVRAMOULI A, TSOCHAS S, MANDALA E, KATODRITOU E, IOANNOU M, RITIS K, SPELETAS M. Methylation status of RASSF1A in patients with chronic myeloid leukemia. Leukemia Research 2009, 33:1130-1132
2. KOUTSOKERA A, KIROPOULOS TS, NIKOULIS DJ, DANIIL ZD, TSOLAKI V, TANOU K, PAPAIOANNOU AI, GERMENIS A, GOURGOULIANIS KI, KOSTIKAS K. Clinical, functional and biochemical changes during recovery from COPD exacerbations. Respiratory Medicine 2009, 103:919-926
3. KARANIKAS V, KHALIL S, KERENIDI T, GOURGOULIANIS KI, GERMENIS AE. Anti-survivin antibody responses in lung cancer. Cancer Letters Apr 18 2009
4. LOULES G, KALALA F, GIANNAKOULAS N, PAPADAKIS E, MATSOUKA P, SPELETAS M,. FIP1L1-PDGFRA molecular analysis in the differential diagnosis of eosinophilia. BMC Blood Disorders 2009, 2;9:1
5. SPELETAS M. The emmerging link between innate immunity and thrombosis. Pathophysiology of Haemostasis and Thrombosis 2008, 36:52-54 (review)
6. KARANIKAS V, SOUKOU F, KALALA F, KERENIDI T, GRAMMOUSTIANOU ES, GOURGOULIANIS KI, GERMENIS AE. Baseline levels of CD8+ T cells against survivin and survivin-2B in the blood of lung cancer patients and cancer-free individuals. Clinical Immunology 2008, 129:230-240
7. KARANIKAS V, SPELETAS M, ZAMANAKOU M, KALALA F, LOULES G, KERENIDI T, GOURGOULIANIS KI, GERMENIS AE. Foxp3 expression in human cancer cells. Journal of Translational Medicine 2008, 6:19
8. KARANIKAS V, TSOHAS S, BOUKAS K, KERENIDI T, NAKOU M, DAHABREH J, POULARAKIS T, GOURGOULIANIS KI, GERMENIS AE. Co-expression patterns of tumor-associated antigen genes by non-small cell lung carcinomas: Implications for immunotherapy. Cancer Biology & Therapy 2008, 7:345-352
9. SPELETAS M, VYZANTIADIS T-A, KALALA F, PLASTIRAS D, KOKOVIADOU K, ANTONIADIS A, KORANTZIS I. Pneumonia caused by Candida krusei and Candida glabrata in a patient with chronic myeloid leukemia receiving imatinib mesylate treatment. Medical Mycology 2008, 46:259-263 (case report)
10. ALEXIOU I, GERMENIS A, KOUTROUMPAS A, KONTOGIANNI A, THEODORIDOU K, SAKKAS LI. Anti-cyclic citrullinated peptide-2 (CCP2) autoantibodies and extra articular manifestations in Greek patients with rheumatoid arthritis. Clinical Rheumatology 2008, 27:511-513
11. RAFAIL S, RITIS K, SCHAEFER K, KOURTZELIS I, SPELETAS M, DOUMAS M, GIAGLIS S, KAMBAS K, KONSTANTINIDES S, KARTALIS G. Leptin induces the expression of functional tissue factor in human neutrophils and peripheral blood mononuclear cells through JAK2- dependent mechanisms and TNF-α involvement. Thrombosis Research 2008, 122:366-375
12. ZOGRAFOS TA, LIASKOS C, RIGOPOULOU EI, TOGOUSIDIS E, MAKARITSIS K, GERMENIS A, DALEKOS GN. Adiponectin: a new independent predictor of liver steatosis and response to IFN-α treatment in chronic hepatitis C? American Journal of Gastroenterology 2007, 102:1-10
13. SPELETAS M, LIADAKI K, KALALA F, DAIOU C, KATODRITOU E, MANDALA E, KORANTZIS I, RITIS K, ZINTZARAS E, GERMENIS AE. TLR4 single nucleotide polymorphisms and thrombosis risk in patients with myeloproliferative disorders. Thrombosis Research 2008, 122:27-32
14. SPELETAS M, KIOUMI A, LOULES G, KATODRITOU E, TSITOURIDIS J, HYTIROGLOU P, CHRISTAKIS J, GERMENIS AE. Analysis of SLC40A1 (ferroportin 1) gene at mRNA level reveals rapidly the causative mutations in patients with hemochromatosis type IV. Blood Cells, Molecules and Diseases 2008, 40:353-359
15. SAKKAS LI, BOULBOU M, KYRIAKOU D, MAKRI I, SINANI C, GERMENIS A, STATHAKIS N. Immunological features of visceral leishmaniasis may mimic systemic lupus erythematosus. Clinical Biochemistry 2008, 41:65-68
16. ZACHAROULIS D, POULTSIDIS A, KATSOGRIDAKIS E, KALALA F, NAKOU M, CHATZITHEOFILOU C. Radiofrequency-assisted partial splenectomy: Histopathological and immunological assessment of the splenic remnant in a porcine model. Surg Endosc 2008, 22:1309-1316
17. KARANIKAS V ZAMANAKOU M, KERENIDI T, DAHABREH J, HEVAS Α, NAKOU Μ, GOURGOULIANIS ΚΙ, GERMENIS AΕ. Indoleamine 2,3-dioxygenase (IDO) expression in lung cancer. Cancer Biology & Therapy 2007, 6:1258-1262
18. ZAMANAKOU M, GERMENIS A, KARANIKAS V. Tumour immune escape mediated by indoleamine 2,3-dioxygenase. Immunology Letters 2007, 111:69-75 (review)
19. ROKA V, POTAMIANOS S, KAPSORITAKIS AN, YIANNAKI EE, KOUKOULIS GN, KOUKOULIS GK, GERMENIS AE. Prevalence of celiac disease in adult population of Central Greece. European Journal of Gastroenterology and Hepatology 2007, 19:982-987
20. PETRIDOU ET, CHAVELAS C, DIKALIOTI SK, DESSYPRIS N, TERZIDIS A, NIKOULIS DI, MARKOPOULOS C, PAPADIAMANTIS Y, GERMENIS AE. Breast cancer risk in relation to most prevalent IgE specific antibodies: a case control study in Greece. Anticancer Research 2007, 27(3B):1709-1713
21. ALEXIOU I, GERMENIS A, ZIOGAS A, THEODORIDOU K, SAKKAS L. Anti-cyclic citrullinated peptide (anti-CCP) antibodies in Greek patients with rheumatoid arthritis. BMC Musculoskeletal Disorders 2007, 8:37
22. KIROPOULOS TS, KOSTIKAS K, OIKONOMIDI S, TSILIONI I, NIKOULIS D, GERMENIS A, GOURGOULIANIS KI. Acute phase markers for the differentiation of infectious and malignant pleural effusions. Respiratory Medicine 2007, 101:910-918
23. THRISKOS P, ZINTZARAS E, GERMENIS AE. DHLAS: A web-based database analysis system to support HLA population studies. Computer Methods and Programs in Biomedicine 2007, 85:267-272
24. GERMENIS AE, KARANIKAS V. Immunoepigenetics: The unseen side of cancer immunoediting. Immunology and Cell Biology 2007, 85:55-59 (theoretical article)
25. METSIOS GS, FLOURIS AD, JAMURTAS TZ, CARRILLO AE, KOURETAS D, GERMENIS AE, GOURGOULIANIS K, KIROPOULOS T, TZATZARAKIS MN, TSATSAKIS AM, KOUTEDAKIS Y. A brief exposure to moderate passive smoke increases metabolism and thyroid hormone secretion. Journal of Clinical Endocrinology and Metabolism 2007, 92:208-211
26. GIAGLIS S, PAPADOPOULOS V, KAMBAS K, DOUMAS M, TSIRONIDOU V, RAFAIL S, KARTALIS G, SPELETAS M, RITIS K. MEFV alterations and population genetics analysis in a large cohort of Greek patients with familial Mediterranean fever. Clinical Genetics 2007, 71:458-467
27. DANIIL Z, KARETSI E, ZAKYNTHINOS E, BAKRATSI E, KALALA F, GOURGOULIANIS KI. Pulmonary arterial hypertension in a patient with common variable immunodeficiency and unilateral bronchiectasis: Successful treatment with iloprost. European Journal of Internal Medicine 2007, 18:333-335 (case report)
28. STEFANOU N, SATRA M, PAPANIKOLAOU V, KALALA F, GATSELIS N, GERMENIS AE, DALEKOS GN, TSEZOU A. Leptin receptor isoforms mRNA expression in peripheral blood mononuclear cells from patients with chronic viral hepatitis. Experimental Biology and Medicine 2006, 231:1653-1663
29. ZOGRAFOS TA, LIASKOS C, TOGOUSIDIS E, ZACHOU K, GATSELIS N, RIGOPOULOU E, GERMENIS AE, DALEKOS GN. Alterations of leptin levels during IFN-α treatment in patients with chronic viral hepatitis B and C. Journal of Hepatology 2006, 44:848-855
30. TSOUTSOU PG, GOURGOULIANIS KI, PETINAKI E, GERMENIS A, TSOUTSOU AG, MPAKA M, EFREMIDOU S, MOLYVDAS P-A. Cytokine levels in the sera of patients with idiopathic pulmonary fibrosis. Pulmonary Medicine 2006, 100:938-945
31. ZINTZARAS E, GERMENIS AE. Diagnostic performance of antibodies against tissue transglutami¬nase for the diagnosis of celiac disease: meta-analysis. Clinical and Vaccine Immunology 2006, 13:187-192
32. GERMENIS AE, KARANIKAS V, GOURGOULIANIS KI. Lung cancer: Immunosurveillance, immunoedit¬ing or immunoepigenetics? Pneumon 2005, 18:291-297 (special article)
33. GERMENIS AE, YIANNAKI EE, ZACHOU K, ROKA V, BARBANIS S, LIASKOS C, ADAM K, KAPSORITAKIS AN, POTAMIANOS S, DALEKOS GN. Prevalence and clinical significance of IgA antibodies against tissue transglutaminase in patients with diverse chronic liver diseases. Clinical and Diagnostic Laboratory Immunology 2005, 12:941-948
34. MASTELLOS D, GERMENIS AE, LAMBRIS JD. Complement: An inflammatory pathway fulfilling multiple roles at the interface of innate immunity and development. Current Drug Targets - Inflammation and Allergy 2005, 4:125-127 (invited review)
35. GERMENIS AE, PATRIKIDOU A. Proteomics challenging medicine. Haema 2005, 8:183-192 (review)
36. KADITIS AG, ALEXOPOULOS, EI, KALAMPOUKA E, KOSTADIMA E, GERMENIS AE, ZINTZARAS E, GOURGOULIANIS K. Morning levels of C-reactive protein in children with obstructive sleep-disordered breathing. American Journal of Respiratory and Critical Care Medicine 2005, 171:282-286
37. BOULBOU MS, KOUKOULIS G, MAKRI E, PETINAKI E, GOURGOULIANIS K, GERMENIS A. Circulating adhesion molecules levels in type 2 diabetes mellitus and hypertension. International Journal of Cardiology 2005, 98:39-44
38. ROUSSAKI-SCHULZE AV, ZAFIRIOU E, NIKOULIS D, KLIMI E, RALLIS E, ZINTZARAS E. Objective biophysical findings in patients with sensitive skin. Drugs Exp Clin Res 2005, 31(Suppl):17-24
39. YIANNAKI EE, ZINTZARAS E, ANALATOS A, THEODORIDOU C, DALEKOS GN, GERMENIS AE. Evaluation of a microsphere-based flow cytometric assay for celiac disease diagnosis. Journal of Immunoassay and Immunochemistry 2004, 25:345-357
40. BOULBOU MS, KOUKOULIS GN, PETINAKI EA, GERMENIS A, GOURGOULIANIS K. Soluble adhesion molecules are not involved in the development of retinopathy in type 2 diabetic patients. Acta Diabetologica 2004, 41:118–122
41. KADITIS AG, ALEXOPOULOS, EI, KALAMPOUKA E, KOSTADIMA E, ANGELOPOULOS N, GERMENIS A, ZINTZARAS E, GOURGOULIANIS K. Morning levels of fibrinogen in children with sleep-disordered breathing. European Respiratory Journal 2004, 24:790-797
42. SKALKIDIS E, GERMENIS AE, PATSOPOULOS N, TRICHOPOULOS D. The impact of Greek publications on the international literature by scientific category. Archives of Hellenic Medicine 2004, 21: 472-479
43. SKALKIDIS E, GERMENIS AE, PATSOPOULOS N, TRICHOPOULOS D. The impact factor of scientific journals by broad category. Archives of Hellenic Medicine 2003, 20:88-122
Congress Abstracts
1. SPELETAS M, PAPADOPOULOU-ALATAKI E, LOULES G, IORDANAKIS G, GERMENIS AE. Novel TACI mutations (V220A and P251L) possibly not implicated in common variable immunodeficiency pathogenesis. 22st European Immunogenetics & Histocompatibility Conference, Toulouse 2008
Tissue Antigens 71:337, 2008
2. KARANIKAS V, SPELETAS M, ZAMANAKOU M, KALALA F, LOULES G, KERENIDI T, GOURGOULIANIS KI, GERMENIS AE. Foxp3 expression in human cancer cells. American Association for Cancer Research (AACR) Annual Meeting, San Diego USA 2008
3. KARANIKAS V, SOUKOU F, KALALA F, KERENIDI T, GOURGOULIANIS KI, GERMENIS AE.
Low-frequency CD8+ T cell precursors specific for survivin and survivin-2B in cancer patients: A caveat for immunotherapy? 8th International Conference on New Trends in Immunosuppression and Immunotherapy, Berlin 2008
4. KARANIKAS V, TSOHAS S, BOUKAS K, KERENIDI T, NAKOU M, DAHABREH J, POULARAKIS T, GOURGOULIANIS KI, GERMENIS AE. Co-expression patterns of tumor-associated antigen genes by non-small cell lung carcinomas: Implications for immunotherapy. International Society for Cellular Oncology Congerss (ISCO 2008), Amsterdam 2008
Cellular Oncology 30:133, 2008
5. KARANIKAS V, SOUKOU F, ZAMANAKOU M, KALALA F, GRAMMOUSTIANOU ES, KERENIDI T, GOURGOULIANIS KI, GERMENIS AE. Quantitative and qualitative assessment of anti-tumour specific T cells in patients with lung cancer and cancer free individuals. International Society for Cellular Oncology Congerss (ISCO 2008), Amsterdam 2008
Cellular Oncology 30:134, 2008
6. KARANIKAS V, ZAMANAKOU M, KERENIDI T, DAHABREH J, HEVAS A, NAKOU M, GOURGOULIANIS KI, GERMENIS AE. Indoleamine 2,3-dioxygenase (IDO) expression in lung cancer. 4th International Greek Biotechnology Forum (IGBF-4), Athens 2008
7. SPELETAS M, LOULES G, GERMANIDIS G, RITIS K, GERMENIS AE. Foxp3 at the crossroad οf immunoregulation, apoptosis and fibrosis in liver diseases. 4th International Greek Biotechnology Forum (IGBF-4), Athens 2008
8. SPELETAS M, GRAMMOUSTIANOU E-S, LOULES G, TSOHAS S, KALALA F, BRAIMI M, MANDALA E, KATODRITOU E, KARANIKAS V, GERMENIS AE. Overexpression of survivin and its variants in the bone marrow of patients with chronic myeloid leukaemia (CML) in remission: Restricting their use in immunotherapy? 4th International Greek Biotechnology Forum (IGBF-4), Athens 2008
9. SPELETAS M, KIOUMI A, LOULES G, KALALA F, KATODRITOU E, TSITOURIDIS I, HYTIROGLOU P, CHRISTAKIS J, KORANTZIS I, GERMENIS A. Analysis of SLC40A1 (Ferroportin 1) gene at mRNA level reveals rapidly the causative mutations in patients with hereditary hemochromatosis type IV. 12th Congress of the European Hematology Association, Vienna 2007
Haematologica 92(Suppl. 1):291, 2007
10. GERMANIDIS G, LOULES G, KOUVELIS L, KARANIKAS V, GIANNOULIS E, RITIS K, GERMENIS A, SPELETAS M. mRNA expression analysis of immunoregulation, apoptosis and fibrosis in liver diseases. 58th Annual Meeting of the American Association for the Study of Liver Diseases, Boston 2007
Hepatology 46(Suppl. S):449A, 2007
11. SPELETAS M, PLASTIRAS D, KALALA F, LIADAKI K, KATODRITOU E, MANDALA E, DAIOU C, RITIS K, KORANTZIS I, GERMENIS A. Innate immunity and thrombosis: Association of TLR4-D299G and TLR4-T399I single nucleotide polymorphisms (SNPs) with thromboembolic disease in patients with myeloproliferative disorders (MPDs). 21st European Immunogenetics & Histocompatibility Conference, Barcelona 2007
Tissue Antigens 69:445, 2007
12. ROKA V, YIANNAKI E, NIKOULIS D, KOUKOULIS G, POTAMIANOS S, GERMENIS A. Prevalence of silent/subclinical celiac disease in Greece. 11th Conference of the European Society of General Medicine/Family Medicine, Kos, Greece, 2005
13. ADAM KP, PRATTI A, ZINTZARAS E, SOUKOU F, NIKOULIS D, STATIRIS C, GERMENIS AE. HLA-A, -B, and -DRB1 analysis of the mixed and two closed populations (Vlachs and Sarakatsans) of Thessaly, Greece. 19th European Immunogenetics & Histocompatibility Conference, Istanbul 2005
Genes & Immunity 6(Suppl. 1): S35, 2005
14. THRISKOS P, ZINTZARAS E, ADAM KP, GERMENIS AE. DHLAS: A web-based database system to support HLA population studies. 19th European Immunogenetics & Histocompatibility Conference, Istanbul 2005
Genes & Immunity 6(Suppl. 1):S79, 2005
15. POTOLODIS E, KOUTALA H, PYROVOLAKI K, DAMIANAKI A, GERMENIS A, ELIOPOULOS GD, PAPADAKI HA. Overexpression of Τoll-like receptors by bone marrow CD14 cells in patients with myelodysplastic syndromes. 10th Congress of the European Hematology Association, Stockholm, Sweden, 2005
Haematologica/The Hematology Journal 90(Suppl. 2):356, 2005
16. LIASKOS C, ZOGRAFOS TA, TOGOUSIDIS E, ZACHOU K, GATSELIS N, RIGOPOULOU E, GERMENIS A, DALEKOS GN. Alterations of leptin levels during IFN-alpha treatment in patients with chronic viral hepatitis B and C: Evidence of an IFN-alpha-mediated suppression of leptin production. 56th Annual Meeting of the American Association for the Study of Liver Diseases, San Francisco, USA, 2005
Hepatology 42(Suppl. 1):673A, 2005
17. ZACHOU K, YIANNAKI EE, ROKA V, LIASKOS C, ADAM K, KAPSORITAKIS AN, GERMENIS AE, DALEKOS GN. Prevalence and clinical significance of IgA antibodies against tissue transglutaminase in patients with diverse chronic liver diseases. 56th Annual Meeting of the American Association for the Study of Liver Diseases, San Francisco, USA, 2005